We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+8.81%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$30.1B
AUM Growth
+$1.02B
Cap. Flow
-$1.16B
Cap. Flow %
-3.87%
Top 10 Hldgs %
22.79%
Holding
1,200
New
104
Increased
364
Reduced
497
Closed
122

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$50.1M
2
CSCO icon
Cisco
CSCO
+$39.1M
3
EW icon
Edwards Lifesciences
EW
+$38.9M
4
ETN icon
Eaton
ETN
+$37.7M
5
BAC icon
Bank of America
BAC
+$36.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$92.9M
2
TXN icon
Texas Instruments
TXN
+$67.4M
3
PFE icon
Pfizer
PFE
+$57.7M
4
FIS icon
Fidelity National Information Services
FIS
+$56.9M
5
TSLA icon
Tesla
TSLA
+$51.5M

Sector Composition

Rank Sector Weight
1 Technology 33.71%
2 Healthcare 19.22%
3 Consumer Discretionary 11.86%
4 Financials 8.66%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEA
451
Easterly Government Properties
DEA
$1.16B
$7.59M 0.03%
209,399
+27,235
+15% +$957K
SLF icon
452
Sun Life Financial
SLF
$45.6B
$7.54M 0.03%
144,600
-55,311
-28% -$2.72M
MSA icon
453
Mine Safety
MSA
$6.79B
$7.52M 0.03%
43,202
+14,719
+52% +$2.11M
EME icon
454
Emcor
EME
$29.9B
$7.5M 0.02%
40,600
-5,600
-12% -$937K
BA icon
455
Boeing
BA
$169B
$7.49M 0.02%
35,469
+6,648
+23% +$1.38M
XENE icon
456
Xenon Pharmaceuticals
XENE
$6.1B
$7.43M 0.02%
193,035
+2,655
+1% +$106K
CERE
457
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$7.43M 0.02%
233,680
+31,947
+16% +$980K
BAX icon
458
Baxter International
BAX
$12.8B
$7.41M 0.02%
162,629
+27,077
+20% +$1.18M
BMI icon
459
Badger Meter
BMI
$3.87B
$7.38M 0.02%
50,000
-20,000
-29% -$2.75M
CTVA icon
460
Corteva
CTVA
$60.5B
$7.36M 0.02%
128,519
-86,657
-40% -$5.06M
SVRA icon
461
Savara
SVRA
$1.08B
$7.31M 0.02%
2,286,403
-542,927
-19% -$1.28M
VAC icon
462
Marriott Vacations Worldwide
VAC
$3.53B
$7.27M 0.02%
59,200
-13,700
-19% -$1.77M
AIG icon
463
American International
AIG
$42.5B
$7.25M 0.02%
125,932
-289
-0.2% -$15.5K
BLMN icon
464
Bloomin' Brands
BLMN
$754M
$7.16M 0.02%
266,425
-51,100
-16% -$1.28M
CBOE icon
465
Cboe Global Markets
CBOE
$32.2B
$7.09M 0.02%
51,350
+1,930
+4% +$263K
BRKR icon
466
Bruker
BRKR
$9.4B
$7.03M 0.02%
+95,100
New +$7.25M
TDC icon
467
Teradata
TDC
$2.88B
$7.01M 0.02%
131,275
-4,700
-3% -$212K
SRPT icon
468
Sarepta Therapeutics
SRPT
$1.64B
$6.93M 0.02%
60,518
+833
+1% +$107K
ARGX icon
469
argenx
ARGX
$55.2B
$6.91M 0.02%
17,719
+243
+1% +$95.6K
AMED
470
DELISTED
Amedisys
AMED
$6.8M 0.02%
74,331
-751
-1% -$61.6K
PSX icon
471
Phillips 66
PSX
$82.9B
$6.79M 0.02%
71,198
-233,586
-77% -$22.7M
BNY
472
Bank of New York Mellon
BNY
$103B
$6.65M 0.02%
149,426
-111,012
-43% -$4.76M
XFOR icon
473
X4 Pharmaceuticals
XFOR
$377M
$6.64M 0.02%
114,166
-32,383
-22% -$1.66M
ELF icon
474
e.l.f. Beauty
ELF
$4.77B
$6.64M 0.02%
58,100
-12,300
-17% -$1.18M
P
475
Everpure Inc
P
$23B
$6.63M 0.02%
+180,000
New +$5.1M

Similar funds

Axa's Q2 2023 Portfolio in Review

As of Q2 2023, Axa held 1,200 positions worth $30.1B, up 3.5% from $29.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Axa withdrew a net $1.16B in Q2 2023, closing 122 positions and reducing 497 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $44.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Axa opened a new position in Lincoln Electric worth $19.9M.

  • Axa's largest Q2 2023 buy was Lincoln Electric: 100,054 shares worth $19.9M.
  • Axa added most to Intuit in Q2 2023, an estimated $50.1M increase.
  • Axa's biggest Q2 2023 reduction was Apple, cutting an estimated $92.9M.
  • Axa fully exited Vanguard S&P 500 ETF in Q2 2023, selling an estimated $44.8M.
  • Axa's ten largest holdings make up 23% of its $30.1B portfolio in Q2 2023.
  • Axa opened 104 new positions and closed 122 in Q2 2023.
  • Axa's portfolio value rose 3.5% quarter-over-quarter to $30.1B.

Based on Axa's 13F filing for Q2 2023, filed 14 Aug 2023.